Rapid and laboratory sars-cov-2 antibody testing in high-risk hospital associated cohorts of unknown covid-19 exposure, a validation and epidemiological study after the first wave of the pandemic

HIGHLIGHTS

• who: Brendan O'Kelly from the Laboratory SARS-Co, Cancer (IARC), France Xiamen University, China have published the Article: Rapid and Laboratory SARS-CoV-2 Antibody Testing in High-Risk Hospital Associated Cohorts of Unknown COVID-19 Exposure, a Validation and Epidemiological Study After the First Wave of the Pandemic, in the Journal: (JOURNAL)
• what: The aim of this study was to assess the asymptomatic seroprevalence of SARS-CoV-2 infection in high-risk patient cohorts that have unavoidable hospital attendances using a rapid SARS-CoV-2 antibody test and laboratory serological assays. Days 2 . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.